目的：探讨难治性免疫性血小板减少性紫癜（ITP）的新的治疗方法。
Objective:To explore the new treating method for refractory ITP.
目的探索对自身免疫性血小板减少性紫癜(AITP)诊断特异和敏感的实验方法。
Objective to investigate a specific and sensitive assay for the diagnosis of autoimmune thrombocytopenic purpura (AITP).
其他被认可的治疗免疫性血小板减少性紫癜病的手段包括：甾体类药物，免疫抑制剂类药物，或者通过外科手术切除患者的脾脏。
Janet Woodcock , head of the FDA's Center for Drug Evaluation and Research. Other approved ITP treatments include steroids, immune-suppressing drugs or surgery to remove the spleen.
其他被认可的治疗免疫性血小板减少性紫癜病的手段包括：甾体类药物，免疫抑制剂类药物，或者通过外科手术切除患者的脾脏。
Janet Woodcock , head of the FDA's Center for Drug Evaluation and Research. Other approved ITP treatments include steroids, immune-suppressing drugs or surgery to remove the spleen.
应用推荐